Upcoming Seminars
7 February 2025
1:00 PM AEDT
Jason Pun, Monash University
Applying and Improving Off-rate Screening by SPR in the Development of FABP4-selective Chemical Probes
Past Seminars
25 July 2024
4:00 PM AEST
Magnus Walter, Monte Rosa Therapeutics
Leaving Serendipity Behind: Rational Discovery and Design of Molecular Glue Degraders
Register here
24 April 2024
10:00 AM AEST
Jack Phelps, Monash University
Development of Zika protease inhibitors using fragment-based drug design
Register here
26 February 2024
2:30 PM AEDT
Dr Roman Hillig, Nuvisan ICB GmbH
PLK1 Inhibitor Co-complex Structures via the Surface Entropy Reduction Approach
24 November 2023
11:00 AM AEDT
Dr Roxanne Smith, Bio21 Institute
Establishing High Throughput Crystallisation Labs with Fragment Screening Capabilities – Eventually the Path Becomes Crystal Clear
31 October 2023
6:00 PM AEDT
Mr Daniel Maddox, Vernalis (R&D) Limited
Automating Challenging Chemistry In Flow: The key to unlocking difficult-to-access libraries in Medicinal Chemistry
26 September 2023
11:00 AM AEST
Dr Christina Spry, Australian National University
Exploiting coenzyme A biosynthesis for antibacterial drug design using fragments
4 September 2023
4:00 PM AEST
Discovery of selective MALT1 inhibitors for T- and B-cell dependent autoimmunity
28 June 2023 4:00 PM AEST
Dr Andrea Testa, Amphista Therapeutics
Adventures and Lesson Learnt in Targeted Protein Degradation
30 March 2023 10:00 AM AEDT
Prof Fabio Almeida, Federal University of Rio de Janeiro
Plant defensins are coreless proteins and a good model to study surface interactions
14 February 2023
11:00 AM AEDT
Dr Joanne Boag, Oncology One Pty Ltd
Challenges and Opportunities in Early-Stage Drug Discovery
23 November 2022
6:30 PM AEDT
A/Prof Anders Bach, University of Copenhagen
Targeting Protein-Protein Interactions Involved in Oxidative Stress using Fragment-Based Drug Discovery
19 October 2022
5:00 PM AEDT
Dr Nir London, Weizmann Institute of Science
Covalent binders – from binding to function
29 August 2022
5:00 PM AEST
Dr Marko Hyvönen, University of Cambridge
Development of inhibitors for BRCA2:RAD51 interaction: a story of fragments, peptides and surrogate systems.
27 July 2022
5:00 PM AEDT
Nessa Carson, Syngenta
TBC
28 June 2022
5:30 PM AEST
15 June 2022
5:00 PM AEST
Dr Jing Dong, Astex Pharmaceuticals
Fragment-Based Drug Discovery:
from X-ray crystallography to Cryo-EM
23 November 2021
6:00 PM AEDT
Dr Ben Davis, Vernalis (R&D) Limited
Biophysics and Fragments:
Taking a Gander and Kicking the Tyres
27 October 2021
10:00 AM AEDT
23 September 2021
5:00 PM AEST
Dr Wolfgang Jahnke, Novartis AG
NMR to support drug discovery by fragment-based approaches and targeted protein degradation
24 June 2021
9:00 AM AEST
A/Professor William C. K. Pomerantz
SAR by 19F NMR: Using Protein-Observed Fluorine NMR for Targeting Protein Complexes.
December 2020
Professor Frank von Delft
Professor Frank von Delft will be talking to us about his work on the Diamond Light Source synchrotron as part of our Centre Forum.
3 November 2020
5:00 – 6:00 PM AEST
A/Professor Kristaps Jaudzem
The ARC CFBD free seminar series presents A/Professor Kristaps Jaudzems from the Latvian Institute of Organic Synthesis, University of Latvia, to talk about successful NMR approaches to FBDD.
6 October 2020
5:00 – 6:00 PM AEST
Dr Jan Wollenhaupt
The first speaker in the ARC CFBD free seminar series is Dr Jan Wollenhaupt from Helmholtz-Zentrum Berlin. In this public online seminar, Dr Wollenhaupt will share insights about their crystallographic fragment screening workflow at the HZB.
ARC Centre for Fragment-Based Design 
